• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cytokinetics Inc

+ Add to Watchlist

CYTK:US

7.7200 USD 0.1500 1.98%

As of 17:20:00 ET on 01/27/2015.

Snapshot for Cytokinetics Inc (CYTK)

Open: 7.6200 Day's Range: 7.5400 - 8.1600 Volume: 889,068
Previous Close: 7.5700 52wk Range: 3.0500 - 13.2600 1-Yr Rtn: -3.26%

Stock Chart for CYTK

No chart data available.
  • CYTK:US 7.7200
  • 1D
  • 1M
  • 1Y
7.5700
Interactive CYTK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4500
Est. EPS (USD) (12/2014) -0.8140
Est. PEG Ratio -
Market Cap (M USD) 282.62
Shares Outstanding (M) 36.61
30 Day Average Volume 668,659
Price/Book (mrq) 3.8384
Price/Sale (ttm) 5.0495
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CYTK

Cytokinetics, Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Robert I BlumPresident/CEOSharon A Barbari "Surrey"Exec VP:Finance/CFO/Secretary
Fady I MalikSenior VP:Research & Early DevAndrew A WolffSenior VP:Clinical Research
More Company Profile & Key Executives for CYTK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil